Target intelligence / Profile preview

Beta Lactamase Enzyme Ambler Class C (AmpC)

Target
AmpC
Molecular classification
Enzyme, Hydrolase, Serine beta-lactamase
01

Overview

Class C beta-lactamases, also known as AmpC beta-lactamases or cephalosporinases, are enzymes produced by certain bacteria that confer resistance to a broad range of beta-lactam antibiotics. These enzymes hydrolyze the beta-lactam ring found in these antibiotics, rendering them ineffective against bacterial cell wall synthesis. They are serine-based enzymes and not inhibited by clavulanic acid or tazobactam. Avibactam can inhibit some class C β-lactamases. Common bacterial hosts include *Enterobacter cloacae*, *Citrobacter freundii*, *Serratia marcescens*, *Morganella morganii*, *Providencia* spp., *Pseudomonas aeruginosa*, and *Escherichia coli*.

Other names
Class C beta lactamaseAmpC beta lactamaseCephalosporinase
02

Mechanism of action

Hydrolyzes the beta-lactam ring of beta-lactam antibiotics, preventing their binding to penicillin-binding proteins and inhibiting bacterial cell wall synthesis.

03

Biological functions

Antibiotic resistanceHydrolysis of beta-lactam antibiotics
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Treatment failures with third-generation cephalosporins despite in vitro susceptibilityInducible resistance leading to unpredictable clinical outcomesLimited effectiveness of traditional beta-lactamase inhibitors (clavulanate, tazobactam)
06

Interacting drugs

Cephalosporins

4 more in the full profile.

Beyond the preview

Go deeper on Beta Lactamase Enzyme Ambler Class C (AmpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta Lactamase Enzyme Ambler Class C (AmpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call